45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
2,199
Insurances with rates
12
CPT / HCPCS codes
439
Most expensive procedures (gross)
1872105
$3,115
adalimumab 40 mg/0.8 mL Subcut Kit
Gross
$4,154
1872548
$2,614
ARIPiprazole 400 mg IM INJ
Gross
$3,485
110; 120; 158
$2,050
Inpatient Rehab Per Diem
Gross
$2,734
110
$2,050
ROOM-BOARD/PVT
Gross
$2,734
120
$2,050
ROOM-BOARD/SEMI
Gross
$2,734
158
$2,050
ROOM-BOARD/WARD
Gross
$2,734
CMG 5001
$2,050
Short-stay cases, length of stay is 3 days or fewer
Gross
$2,734
1874662
$1,688
denosumab 60 mg/mL Subcut Soln 1 mL
Gross
$2,251
1880731
$1,618
teduglutide 5 mg Subcut Kit
Gross
$2,158
1880781
$1,609
teriparatide 620 mcg/2.48 mL Subcut Device 2.48 mL
Gross
$2,145
1881200
$1,548
tuberculin purified protein derivative 5 tuberculin units/0.1 mL Intradermal Soln 1 mL MDV
Gross
$2,064
1873479
$1,409
calcitonin 200 intl units/mL Inj Soln 2 mL
Gross
$1,879
1879457
$1,027
pomalidomide 4 mg Cap
Gross
$1,370
1881704
$962
epoetin alfa 40,000 units/mL preservative-free Sol
Gross
$1,283
A4220
$863
A4220 Refill Kit for implantable infusion pump
Gross
$1,150
93971
$794
US DUPLEX VEIN LEFT LOWER EXTREMITY* (HDRS)
Gross
$1,059
93970
$728
US DUPLEX VEIN BILATERAL LOWER EXTREMITY* (HDRS)
Gross
$970
64605
$656
Destruction by neurolytic agent, procedures on somatic/trigeminal nerve V2/V3 64605
Gross
$875
64635
$641
Neurolyt agent/lumb/sac/sng jt/bilat 64635
Gross
$854
1880734
$616
telavancin 750 mg IV Inj
Gross
$821
95913
$598
Nerve conduction study/>13 study 95913
Gross
$797
76700
$589
US ABDOMINAL COMPLETE* (HDRS)
Gross
$785
64625
$561
Destruction by neurolytic agent, procedures on somatic/sacral nerve, bilat 64625
Gross
$748
J3490
$557
J3490 drugs unclassified injection (Charge)
Gross
$743
1881782
$541
onabotulinumtoxinA 100 units Inj
Gross
$721
95912
$518
Nerve conduction study/11-12 study 95912
Gross
$690
2498080
$486
tirzepatide pen 5 mg/0.5 mL Sol
Gross
$648
1881698
$481
epoetin alfa 20,000 units/mL Inj Soln 1 mL
Gross
$641
95864
$469
Needle EMG/4 extrem 95864
Gross
$625
87502
$461
Influenza type A and B, RT-PCR* (DLS)
Gross
$615
95911
$440
Nerve conduction study/9-10 study 95911
Gross
$587
64633
$439
Neurolytic agent/cerv/thor sng jt 64633
Gross
$586
72200
$436
XR SACROILIAC JOINTS COMPLETE MIN 3V* (HDRS)
Gross
$581
64624
$426
Destruction by neurolytic agent, procedures on somatic/genicular nerve, bilat 64624
Gross
$568
1874610
$401
DAPTOmycin 500 mg IV Inj
Gross
$535
1882287
$399
dulaglutide 0.75 mg/0.5 mL UD
Gross
$532
1882288
$399
dulaglutide 1.5 mg/0.5 mL UD
Gross
$532
1876408
$393
glatiramer 40 mg/mL Subcut Soln 1 mL
Gross
$524
36430
$385
BLOOD TRANSFUSION
Gross
$513
87426
$385
SARS CoV-2 (COVID-19) Real-time PCR* (DLS)
Gross
$513
87811
$385
SARS COVID Antigen* (DLS)
Gross
$513
99223
$380
99223 initial hospital care/day 75 minutes (Charge)
Gross
$507
92523
$379
SLP Eval Lang Comprehension,Express Unit
Gross
$506
92612
$378
SLP Fiberoptic Swallow Eval Units
Gross
$504
73564
$375
XR BILATERAL KNEES COMPLETE 3V* (HDRS)
Gross
$500
1882259
$374
avibactam-cefTAZidime 0.5 g-2 g IV Inj
Gross
$498
95910
$363
Nerve conduction study/7-8 study 95910
Gross
$484
92522
$361
SLP Eval of Speech Sound Prod Units
Gross
$482
73590
$358
XR LEFT TIBIA-FIBULA 2V* (HDRS)
Gross
$477
71046
$348
XR CHEST PA AND LATERAL WITH OBLIQUES* (HDRS)
Gross
$464
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 1872105 | adalimumab 40 mg/0.8 mL Subcut Kit | $4,154 | $3,115 | — | — | 11 |
| 1872548 | ARIPiprazole 400 mg IM INJ | $3,485 | $2,614 | — | — | 11 |
| 110; 120; 158 | Inpatient Rehab Per Diem | $2,734 | $2,050 | — | — | 11 |
| 110 | ROOM-BOARD/PVT | $2,734 | $2,050 | — | — | 17 |
| 120 | ROOM-BOARD/SEMI | $2,734 | $2,050 | — | — | 17 |
| 158 | ROOM-BOARD/WARD | $2,734 | $2,050 | — | — | 17 |
| CMG 5001 | Short-stay cases, length of stay is 3 days or fewer | $2,734 | $2,050 | — | — | 21 |
| 1874662 | denosumab 60 mg/mL Subcut Soln 1 mL | $2,251 | $1,688 | — | — | 11 |
| 1880731 | teduglutide 5 mg Subcut Kit | $2,158 | $1,618 | — | — | 11 |
| 1880781 | teriparatide 620 mcg/2.48 mL Subcut Device 2.48 mL | $2,145 | $1,609 | — | — | 11 |
| 1881200 | tuberculin purified protein derivative 5 tuberculin units/0.1 mL Intradermal Soln 1 mL MDV | $2,064 | $1,548 | — | — | 11 |
| 1873479 | calcitonin 200 intl units/mL Inj Soln 2 mL | $1,879 | $1,409 | — | — | 11 |
| 1879457 | pomalidomide 4 mg Cap | $1,370 | $1,027 | — | — | 11 |
| 1881704 | epoetin alfa 40,000 units/mL preservative-free Sol | $1,283 | $962 | — | — | 11 |
| A4220 | A4220 Refill Kit for implantable infusion pump | $1,150 | $863 | — | — | 11 |
| 93971 | US DUPLEX VEIN LEFT LOWER EXTREMITY* (HDRS) | $1,059 | $794 | — | — | 15 |
| 93970 | US DUPLEX VEIN BILATERAL LOWER EXTREMITY* (HDRS) | $970 | $728 | — | — | 15 |
| 64605 | Destruction by neurolytic agent, procedures on somatic/trigeminal nerve V2/V3 64605 | $875 | $656 | — | — | 15 |
| 64635 | Neurolyt agent/lumb/sac/sng jt/bilat 64635 | $854 | $641 | — | — | 15 |
| 1880734 | telavancin 750 mg IV Inj | $821 | $616 | — | — | 11 |
| 95913 | Nerve conduction study/>13 study 95913 | $797 | $598 | — | — | 15 |
| 76700 | US ABDOMINAL COMPLETE* (HDRS) | $785 | $589 | — | — | 15 |
| 64625 | Destruction by neurolytic agent, procedures on somatic/sacral nerve, bilat 64625 | $748 | $561 | — | — | 15 |
| J3490 | J3490 drugs unclassified injection (Charge) | $743 | $557 | — | — | 11 |
| 1881782 | onabotulinumtoxinA 100 units Inj | $721 | $541 | — | — | 11 |
| 95912 | Nerve conduction study/11-12 study 95912 | $690 | $518 | — | — | 15 |
| 2498080 | tirzepatide pen 5 mg/0.5 mL Sol | $648 | $486 | — | — | 11 |
| 1881698 | epoetin alfa 20,000 units/mL Inj Soln 1 mL | $641 | $481 | — | — | 11 |
| 95864 | Needle EMG/4 extrem 95864 | $625 | $469 | — | — | 15 |
| 87502 | Influenza type A and B, RT-PCR* (DLS) | $615 | $461 | — | — | 11 |
| 95911 | Nerve conduction study/9-10 study 95911 | $587 | $440 | — | — | 15 |
| 64633 | Neurolytic agent/cerv/thor sng jt 64633 | $586 | $439 | — | — | 15 |
| 72200 | XR SACROILIAC JOINTS COMPLETE MIN 3V* (HDRS) | $581 | $436 | — | — | 15 |
| 64624 | Destruction by neurolytic agent, procedures on somatic/genicular nerve, bilat 64624 | $568 | $426 | — | — | 15 |
| 1874610 | DAPTOmycin 500 mg IV Inj | $535 | $401 | — | — | 11 |
| 1882287 | dulaglutide 0.75 mg/0.5 mL UD | $532 | $399 | — | — | 11 |
| 1882288 | dulaglutide 1.5 mg/0.5 mL UD | $532 | $399 | — | — | 11 |
| 1876408 | glatiramer 40 mg/mL Subcut Soln 1 mL | $524 | $393 | — | — | 11 |
| 36430 | BLOOD TRANSFUSION | $513 | $385 | — | — | 15 |
| 87426 | SARS CoV-2 (COVID-19) Real-time PCR* (DLS) | $513 | $385 | — | — | 11 |
| 87811 | SARS COVID Antigen* (DLS) | $513 | $385 | — | — | 11 |
| 99223 | 99223 initial hospital care/day 75 minutes (Charge) | $507 | $380 | — | — | 15 |
| 92523 | SLP Eval Lang Comprehension,Express Unit | $506 | $379 | — | — | 15 |
| 92612 | SLP Fiberoptic Swallow Eval Units | $504 | $378 | — | — | 15 |
| 73564 | XR BILATERAL KNEES COMPLETE 3V* (HDRS) | $500 | $375 | — | — | 15 |
| 1882259 | avibactam-cefTAZidime 0.5 g-2 g IV Inj | $498 | $374 | — | — | 11 |
| 95910 | Nerve conduction study/7-8 study 95910 | $484 | $363 | — | — | 15 |
| 92522 | SLP Eval of Speech Sound Prod Units | $482 | $361 | — | — | 15 |
| 73590 | XR LEFT TIBIA-FIBULA 2V* (HDRS) | $477 | $358 | — | — | 15 |
| 71046 | XR CHEST PA AND LATERAL WITH OBLIQUES* (HDRS) | $464 | $348 | — | — | 15 |
Showing top 50 of 2,199 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.